The SIX1 expression and drug resistance studies showed that SIX1 and drug responses are inversely related; SIX1 downregulation caused drug sensitivity, and SIX1 overexpression enhanced drug resistance in breast and ovarian cancer cells.8,24. Here, SIX1 is linked to ovarian carcinoma.